Clinical & Translational Oncology

Papers
(The TQCC of Clinical & Translational Oncology is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Benefits of early salvage therapy on oncological outcomes in high-risk prostate cancer with persistent PSA after radical prostatectomy55
MiR-493-5p inhibits the malignant development of gliomas via suppressing E2F3-mediated dysfunctions of P53 and PI3K/AKT pathways52
SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis51
Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus36
Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group34
The TRIM proteins in cancer: from expression to emerging regulatory mechanisms31
Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism25
Circulating exosomal miRNAs and cancer early diagnosis25
PD1/PDL1 expression is associated with increased TIM3 expression and tumor-infiltrating T lymphocytes in fibroblastic tumors24
Human umbilical cord mesenchymal stem cell-derived exosomes carrying hsa-miRNA-128-3p suppress pancreatic ductal cell carcinoma by inhibiting Galectin-324
The effects of aerobic exercise on the intestinal tumors and flora of the ApcMin/+ mouse20
Multidisciplinary consensus on the criteria for fertility preservation in cancer patients20
0.11066293716431